Alzheimer's Disease Clinical Trials in Los Angeles

Showing 81-100 of 247 trials

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

NCT04851691

The goal of this study will be to design, implement and test the impact of a quality improvement (QI) intervention that uses an EHR CDS tool among physicians newly ordering an antipsychotic medication for older adults with ADRD. The study team hypothesizes that the intervention will reduce each participating clinician's pill days per patient prescribed.

Alzheimer DiseaseDementia AlzheimersDementia of Alzheimer Type

University of California, Los Angeles158 participantsStarted Aug 2021

Los Angeles, California, United States

RECRUITINGNA< 1 mile

Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease

NCT05417555

The goal of this study is to investigate whether Low Intensity Focused Ultrasound Pulsation (LIFUP) targeting a part of the brain involved in memory will have an affect on brain activity and whether it may improve memory in people with Mild Cognitive Impairment and Mild Alzheimer's Disease. The main questions the study seeks to answer are: 1. Can LIFUP increase brain activity in the targeted area? 2. Can LIFUP improve memory in people with MCI and mild AD? 3. Can LIFUP improve connectivity of memory networks in the brain? Participants in this study will complete MRIs and memory testing, and receive Low Intensity Focused Ultrasound to a part of their brain involved in memory (the entorhinal cortex).

Mild Cognitive ImpairmentAmnestic Mild Cognitive DisorderDeep Brain Stimulation+1 more

University of California, Los Angeles144 participantsStarted Sep 2022

Los Angeles, California, United States

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease

Alzheimer's Disease Trials in Other Cities

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Intranasal Oxytocin for Frontotemporal Dementia

Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Nicotinamide as an Early Alzheimer's Disease Treatment

Smartphone App to Improve Physical Activity in Older Adults With MCI/Mild Dementia

A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)

A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

Addressing Dementia Via Agitation-Centered Evaluation

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia

Synuclein-One Study

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease

Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome

Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Other Conditions in Los Angeles